Myanmar vs Solomon Islands: Average non-HDL cholesterol levels
Myanmar
3.7
in 2018
Solomon Islands
3.7
in 2018
Myanmar rank
12th
Solomon Islands rank
12th
Average non-HDL cholesterol levels over time
- Myanmar
- Solomon Islands
How they compare
Myanmar currently reports 3.7 against 3.7 in Solomon Islands, a difference of 0.
The two have swapped places 2 times across 39 shared years of data; in 1980 it was Solomon Islands ahead.
Myanmar ranks 12th and Solomon Islands ranks 12th of 191 countries.
Solomon Islands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Myanmar | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.05 | 3.32 | 0.27 | Solomon Islands |
| 1990s | 3.16 | 3.45 | 0.29 | Solomon Islands |
| 2000s | 3.37 | 3.52 | 0.15 | Solomon Islands |
| 2010s | 3.62 | 3.62 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Myanmar or Solomon Islands?
- Myanmar, at 3.7 against 3.7 in Solomon Islands as of 2018.
- What is the difference in average non-hdl cholesterol levels between Myanmar and Solomon Islands?
- 0, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Solomon Islands?
- 39 years are reported by both, from 1980 to 2018.
- How do Myanmar and Solomon Islands rank globally for average non-hdl cholesterol levels?
- Myanmar ranks 12th and Solomon Islands ranks 12th of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.